| scholarly article | Q13442814 |
| P50 | author | Siegfried Kasper | Q2283474 |
| Lukas Pezawas | Q42305729 | ||
| P2093 | author name string | Christian Scharinger | |
| Ulrich Rabl | |||
| P2860 | cites work | Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication | Q22253031 |
| A Swedish National Twin Study of Lifetime Major Depression | Q22306276 | ||
| Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits | Q24603974 | ||
| Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis | Q24609513 | ||
| The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia | Q24619976 | ||
| The subgenual anterior cingulate cortex in mood disorders | Q24649017 | ||
| 5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data | Q24650432 | ||
| The molecular neurobiology of depression | Q24656261 | ||
| A genomewide association study of citalopram response in major depressive disorder | Q24656746 | ||
| Serotonin-1A receptor imaging in recurrent depression: replication and literature review | Q24657080 | ||
| A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans | Q24681350 | ||
| The personality trait openness is related to cerebral 5-HTT levels | Q27115023 | ||
| Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene | Q27860482 | ||
| Long story short: the serotonin transporter in emotion regulation and social cognition | Q27863369 | ||
| PET imaging of serotonin 1A receptor binding in depression | Q28138956 | ||
| The endophenotype concept in psychiatry: etymology and strategic intentions | Q28187744 | ||
| Role of genotype in the cycle of violence in maltreated children | Q28216871 | ||
| Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response | Q28256653 | ||
| Neurobiological and clinical effects of the antidepressant tianeptine | Q28260673 | ||
| Culture-gene coevolution of individualism-collectivism and the serotonin transporter gene | Q28262804 | ||
| Intermediate phenotypes and genetic mechanisms of psychiatric disorders | Q28264588 | ||
| Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder | Q28271610 | ||
| Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression | Q28272707 | ||
| A functional polymorphism in the monoamine oxidase A gene promoter | Q28287498 | ||
| Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region | Q28297391 | ||
| Synthesis of serotonin by a second tryptophan hydroxylase isoform | Q28513857 | ||
| Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies | Q28751388 | ||
| Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression | Q28943274 | ||
| Genome-wide association study of recurrent early-onset major depressive disorder | Q28943558 | ||
| MAOA, maltreatment, and gene–environment interaction predicting children's mental health: new evidence and a meta-analysis | Q29012785 | ||
| Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. | Q29417150 | ||
| The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function | Q29615582 | ||
| Deep brain stimulation for treatment-resistant depression | Q29616769 | ||
| Serotonin transporter genetic variation and the response of the human amygdala | Q29617804 | ||
| 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression | Q29618835 | ||
| Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis | Q29619093 | ||
| Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635 | Q29999635 | ||
| Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission. | Q30494258 | ||
| Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine | Q30531104 | ||
| Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects | Q37266718 | ||
| Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism | Q37286925 | ||
| Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety | Q37328993 | ||
| Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis | Q37370760 | ||
| The structural integrity of an amygdala-prefrontal pathway predicts trait anxiety | Q37469424 | ||
| The role of pharmacogenetics in the treatment of depression and anxiety disorders | Q37593913 | ||
| Imaging genetics--days of future past | Q37676588 | ||
| Electroconvulsive therapy: a review of knowledge, experience and attitudes of patients concerning the treatment | Q37686538 | ||
| WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry | Q37690334 | ||
| Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. | Q38435480 | ||
| 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants | Q39281683 | ||
| Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders | Q39483344 | ||
| Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects | Q39983098 | ||
| Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans | Q40012224 | ||
| Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity | Q40036871 | ||
| Characterization of a functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonergic raphe neurons | Q40119932 | ||
| Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription | Q40429613 | ||
| Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study | Q42074509 | ||
| A genomewide association study of citalopram response in major depressive disorder-a psychometric approach | Q42464234 | ||
| Genome-wide pharmacogenetics of antidepressant response in the GENDEP project | Q42655084 | ||
| Association of the 5- HTTLPR genotype and unipolar depression: a meta-analysis | Q43104615 | ||
| Effect of tryptophan hydroxylase-2 gene variants on amygdalar and hippocampal volumes. | Q43120847 | ||
| Effect of electroconvulsive therapy on 5-HT1A receptor binding in patients with depression: a PET study with [11C]WAY 100635. | Q43196377 | ||
| Emotion specific modulation of automatic amygdala responses by 5-HTTLPR genotype. | Q43229384 | ||
| Baseline brain perfusion and the serotonin transporter promoter polymorphism. | Q43251505 | ||
| Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study | Q43260686 | ||
| Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia | Q43284373 | ||
| No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression | Q43294900 | ||
| 'Negativity bias' in risk for depression and anxiety: brain-body fear circuitry correlates, 5-HTT-LPR and early life stress | Q43429980 | ||
| Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies | Q44066592 | ||
| Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism | Q44239950 | ||
| Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders | Q44355507 | ||
| Reduced serotonin type 1A receptor binding in panic disorder. | Q44737226 | ||
| Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression | Q44752400 | ||
| Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. | Q50788443 | ||
| Imaging genetics: Progressing by leaps and bounds | Q51839583 | ||
| A glimmer of light for neuropsychiatric disorders | Q51877526 | ||
| The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. | Q51935722 | ||
| Allelic Variation of Human Serotonin Transporter Gene Expression | Q55934627 | ||
| Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts | Q57323019 | ||
| Consensus nomenclature for in vivo imaging of reversibly binding radioligands | Q34630958 | ||
| Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder | Q34658088 | ||
| Childhood stress, serotonin transporter gene and brain structures in major depression | Q34660587 | ||
| Neurocircuitry of mood disorders | Q34660904 | ||
| Is it time to reassess the BDNF hypothesis of depression? | Q34663655 | ||
| Meta-analyses of genetic studies on major depressive disorder | Q34701323 | ||
| Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response | Q34743434 | ||
| Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression | Q34762522 | ||
| Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies | Q34781872 | ||
| Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder | Q34871885 | ||
| Neural correlates of epigenesis | Q35070669 | ||
| Genetic risk profiles for depression and anxiety in adult and elderly cohorts | Q35126132 | ||
| The developmental role of serotonin: news from mouse molecular genetics | Q35584090 | ||
| Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635. | Q35662761 | ||
| A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression | Q35737324 | ||
| Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings | Q36666237 | ||
| Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. | Q36679249 | ||
| Brain monoamine oxidase A activity predicts trait aggression | Q36725858 | ||
| Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. | Q36892482 | ||
| Interaction between BDNF and serotonin: role in mood disorders | Q36946551 | ||
| Important messages in the 'post': recent discoveries in 5-HT neurone feedback control | Q36998547 | ||
| Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo | Q37036555 | ||
| Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis | Q37060401 | ||
| Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain | Q37242079 | ||
| Hippocampal volume and depression: a meta-analysis of MRI studies | Q30974294 | ||
| Predictors of amygdala activation during the processing of emotional stimuli: a meta-analysis of 385 PET and fMRI studies. | Q31139887 | ||
| Volumetric MRI studies of the hippocampus in major depressive disorder: Meanings of inconsistency and directions for future research | Q33427001 | ||
| Hippocampal changes associated with early-life adversity and vulnerability to depression | Q33649329 | ||
| Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder | Q33723741 | ||
| Escitalopram effects on insula and amygdala BOLD activation during emotional processing | Q33730062 | ||
| Serotonin transporter genotype modulates amygdala activity during mood regulation. | Q33736045 | ||
| Decreased hippocampal volume in healthy girls at risk of depression | Q33752419 | ||
| Genetic epidemiology of major depression: review and meta-analysis | Q33919509 | ||
| Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task | Q33922872 | ||
| The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update | Q34020661 | ||
| fMRI reveals amygdala activation to human faces in social phobics | Q34066613 | ||
| Antidepressant response and the serotonin transporter gene-linked polymorphic region | Q34088515 | ||
| Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study | Q34101325 | ||
| Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain. | Q34111111 | ||
| Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits. | Q34282479 | ||
| Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice | Q34363151 | ||
| Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression | Q34381106 | ||
| A susceptibility gene for affective disorders and the response of the human amygdala | Q34392171 | ||
| A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity | Q34437037 | ||
| The yin and yang of neurotrophin action | Q34439423 | ||
| Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study | Q34449923 | ||
| Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. | Q34462273 | ||
| Linking Molecules to Mood: New Insight Into the Biology of Depression | Q34540304 | ||
| Reduced serotonin-1A receptor binding in social anxiety disorder | Q34566534 | ||
| World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care | Q34578945 | ||
| Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. | Q34592393 | ||
| Neural mechanisms of genetic risk for impulsivity and violence in humans | Q34597413 | ||
| Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. | Q34599330 | ||
| Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype | Q34602395 | ||
| Genomewide association studies: history, rationale, and prospects for psychiatric disorders | Q34606096 | ||
| The serotonin-1A receptor in anxiety disorders | Q34607362 | ||
| 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. | Q34615479 | ||
| Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. | Q44813014 | ||
| Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain | Q44934932 | ||
| Tryptophan hydroxylase-2 controls brain serotonin synthesis | Q44973406 | ||
| Ethnic differences in the serotonin transporter polymorphism (5-HTTLPR) in several European populations | Q45011870 | ||
| Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study | Q45047364 | ||
| Serotonin 1A receptor binding and treatment response in late-life depression | Q45106413 | ||
| Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders | Q45172625 | ||
| Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter | Q45183612 | ||
| Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men. | Q45980872 | ||
| Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. | Q46030165 | ||
| 5-HTT genotype effect on prefrontal-amygdala coupling differs between major depression and controls. | Q46039998 | ||
| Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits | Q46194967 | ||
| Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression | Q46246967 | ||
| Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems | Q46329587 | ||
| Serotonergic genes and amygdala activity in response to negative affective facial stimuli in Korean women | Q46338998 | ||
| Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6. | Q46458112 | ||
| MAO A VNTR polymorphism and variation in human morphology: a VBM study. | Q46505844 | ||
| Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women | Q46531757 | ||
| Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style | Q46543887 | ||
| Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. | Q46577196 | ||
| The serotonin transporter length polymorphism, neuroticism, and depression: a comprehensive assessment of association | Q46603268 | ||
| Monoamine oxidase A-uVNTR genotype affects limbic brain activity in response to affective facial stimuli | Q46664376 | ||
| Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide | Q46727188 | ||
| Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations | Q46735169 | ||
| Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression | Q46744329 | ||
| Genetic variation in the serotonin transporter modulates neural system-wide response to fearful faces | Q46759593 | ||
| Genetic architecture of the human tryptophan hydroxylase 2 Gene: existence of neural isoforms and relevance for major depression | Q46818746 | ||
| Functional coupling of the amygdala in depressed patients treated with antidepressant medication | Q46911638 | ||
| BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects | Q46915507 | ||
| Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. | Q46923228 | ||
| BDNF, relative preference, and reward circuitry responses to emotional communication | Q47958150 | ||
| Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality | Q48159342 | ||
| Amygdala hypersensitivity in response to emotional faces in Tourette's patients | Q48160271 | ||
| Intermediate or brainless phenotypes for psychiatric research? | Q48169546 | ||
| Genetic variation in serotonin transporter alters resting brain function in healthy individuals | Q48178578 | ||
| A validated network of effective amygdala connectivity | Q48181024 | ||
| Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression | Q48219987 | ||
| Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. | Q48261354 | ||
| Psychiatry. Beyond DSM: seeking a brain-based classification of mental illness | Q48267637 | ||
| Serotonergic genes modulate amygdala activity in major depression | Q48281587 | ||
| Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study | Q48289563 | ||
| Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity | Q48407827 | ||
| Automatic mood-congruent amygdala responses to masked facial expressions in major depression. | Q48461051 | ||
| Neuroticism modulates amygdala-prefrontal connectivity in response to negative emotional facial expressions. | Q48484334 | ||
| Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals | Q48619150 | ||
| Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study | Q48904887 | ||
| Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. | Q48967630 | ||
| Regional brain volume in depression and anxiety disorders | Q49018204 | ||
| The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study | Q49118049 | ||
| The missing link between clinical endpoints and drug targets in depression | Q50709240 | ||
| P433 | issue | 7 | |
| P921 | main subject | major depressive disorder | Q42844 |
| P304 | page(s) | 474-488 | |
| P577 | publication date | 2011-08-11 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | World Journal of Biological Psychiatry | Q15759917 |
| P1476 | title | The genetic blueprint of major depressive disorder: contributions of imaging genetics studies | |
| P478 | volume | 12 |
| Q36737217 | Epigenetic Modulation of Mood Disorders |
| Q26996269 | From psychiatric disorders to animal models: a bidirectional and dimensional approach |
| Q38045099 | Gene, brains, and environment—genetic neuroimaging of depression |
| Q35957857 | Imaging-Genetics in Autism Spectrum Disorder: Advances, Translational Impact, and Future Directions |
| Q48082633 | Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression |
| Q34688887 | Modulatory Effects of the Piccolo Genotype on Emotional Memory in Health and Depression |
| Q51738419 | Neuroimaging genomic studies in major depressive disorder: A systematic review. |
| Q46116416 | No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression |
| Q35131170 | Platelet serotonin transporter function predicts default-mode network activity |
| Q85907009 | Serotonin transporter gene and stress reactivity in unipolar depression. Role of the HPA system as endophenotype of the SLC6A4 gene |
| Q38078013 | The Implications of Genomics on the Nursing Care of Adults With Neuropsychiatric Conditions |
| Q38838410 | The genetics of anxiety-related negative valence system traits. |
| Q24020123 | fMRI measurements of amygdala activation are confounded by stimulus correlated signal fluctuation in nearby veins draining distant brain regions |
| Q36584886 | microRNAs as Biomarker in Depression Pathogenesis |
Search more.